Heron Therapeutics (HRTX) Leases (2019 - 2025)
Historic Leases for Heron Therapeutics (HRTX) over the last 9 years, with Q3 2025 value amounting to $708000.0.
- Heron Therapeutics' Leases fell 7959.07% to $708000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $708000.0, marking a year-over-year decrease of 7959.07%. This contributed to the annual value of $2.8 million for FY2024, which is 4874.95% down from last year.
- According to the latest figures from Q3 2025, Heron Therapeutics' Leases is $708000.0, which was down 7959.07% from $1.4 million recorded in Q2 2025.
- In the past 5 years, Heron Therapeutics' Leases registered a high of $15.6 million during Q1 2021, and its lowest value of $708000.0 during Q3 2025.
- For the 5-year period, Heron Therapeutics' Leases averaged around $7.0 million, with its median value being $6.5 million (2023).
- Its Leases has fluctuated over the past 5 years, first tumbled by 1450.19% in 2021, then crashed by 7959.07% in 2025.
- Quarter analysis of 5 years shows Heron Therapeutics' Leases stood at $9.8 million in 2021, then decreased by 22.22% to $7.6 million in 2022, then decreased by 28.87% to $5.4 million in 2023, then crashed by 48.75% to $2.8 million in 2024, then tumbled by 74.6% to $708000.0 in 2025.
- Its Leases stands at $708000.0 for Q3 2025, versus $1.4 million for Q2 2025 and $2.1 million for Q1 2025.